The injection, available in a 50 mEq/50 mL (1 mEq/mL) single-dose vial, is bioequivalent and therapeutically equivalent to Abbott Laboratories’ reference listed drug, the company said in an exchange filing.
The injection, available in a 50 mEq/50 mL (1 mEq/mL) single-dose vial, is bioequivalent and therapeutically equivalent to Abbott Laboratories’ reference listed drug, the company said in an exchange filing.